Author Correction: Noncanonical binding of Lck to CD3ε promotes TCR signaling and CAR function.

Autor: Hartl FA; Faculty of Biology, Albert-Ludwigs-University of Freiburg, Freiburg, Germany.; Signalling Research Centres BIOSS and CIBSS, University of Freiburg, Freiburg, Germany.; Center of Chronic Immunodeficiency CCI, University Clinics and Medical Faculty, Freiburg, Germany., Beck-Garcìa E; Faculty of Biology, Albert-Ludwigs-University of Freiburg, Freiburg, Germany., Woessner NM; Faculty of Biology, Albert-Ludwigs-University of Freiburg, Freiburg, Germany.; Signalling Research Centres BIOSS and CIBSS, University of Freiburg, Freiburg, Germany.; Spemann Graduate School of Biology and Medicine (SGBM), Albert-Ludwigs-University Freiburg, Freiburg, Germany., Flachsmann LJ; Faculty of Biology, Albert-Ludwigs-University of Freiburg, Freiburg, Germany., Cárdenas RMV; Faculty of Biology, Albert-Ludwigs-University of Freiburg, Freiburg, Germany.; Signalling Research Centres BIOSS and CIBSS, University of Freiburg, Freiburg, Germany., Brandl SM; Faculty of Biology, Albert-Ludwigs-University of Freiburg, Freiburg, Germany.; Signalling Research Centres BIOSS and CIBSS, University of Freiburg, Freiburg, Germany.; Spemann Graduate School of Biology and Medicine (SGBM), Albert-Ludwigs-University Freiburg, Freiburg, Germany., Taromi S; Department of Medicine I, Medical Center, University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Faculty of Medical and Life Sciences, Furtwangen University, Campus VS-Schwenningen, Furtwangen, Germany., Fiala GJ; Faculty of Biology, Albert-Ludwigs-University of Freiburg, Freiburg, Germany.; Signalling Research Centres BIOSS and CIBSS, University of Freiburg, Freiburg, Germany., Morath A; Faculty of Biology, Albert-Ludwigs-University of Freiburg, Freiburg, Germany.; Signalling Research Centres BIOSS and CIBSS, University of Freiburg, Freiburg, Germany.; Spemann Graduate School of Biology and Medicine (SGBM), Albert-Ludwigs-University Freiburg, Freiburg, Germany., Mishra P; Pharmaceutical Bioinformatics, Albert-Ludwigs-University of Freiburg, Freiburg, Germany., Yousefi OS; Faculty of Biology, Albert-Ludwigs-University of Freiburg, Freiburg, Germany.; Signalling Research Centres BIOSS and CIBSS, University of Freiburg, Freiburg, Germany.; Spemann Graduate School of Biology and Medicine (SGBM), Albert-Ludwigs-University Freiburg, Freiburg, Germany., Zimmermann J; Faculty of Biology, Albert-Ludwigs-University of Freiburg, Freiburg, Germany., Hoefflin N; Faculty of Biology, Albert-Ludwigs-University of Freiburg, Freiburg, Germany.; Signalling Research Centres BIOSS and CIBSS, University of Freiburg, Freiburg, Germany., Köhn M; Faculty of Biology, Albert-Ludwigs-University of Freiburg, Freiburg, Germany.; Signalling Research Centres BIOSS and CIBSS, University of Freiburg, Freiburg, Germany., Wöhrl BM; Biopolymers, University of Bayreuth, Bayreuth, Germany., Zeiser R; Signalling Research Centres BIOSS and CIBSS, University of Freiburg, Freiburg, Germany.; Department of Medicine I, Medical Center, University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Schweimer K; Biopolymers, University of Bayreuth, Bayreuth, Germany., Günther S; Pharmaceutical Bioinformatics, Albert-Ludwigs-University of Freiburg, Freiburg, Germany., Schamel WW; Faculty of Biology, Albert-Ludwigs-University of Freiburg, Freiburg, Germany.; Signalling Research Centres BIOSS and CIBSS, University of Freiburg, Freiburg, Germany.; Center of Chronic Immunodeficiency CCI, University Clinics and Medical Faculty, Freiburg, Germany., Minguet S; Faculty of Biology, Albert-Ludwigs-University of Freiburg, Freiburg, Germany. susana.minguet@biologie.uni-freiburg.de.; Signalling Research Centres BIOSS and CIBSS, University of Freiburg, Freiburg, Germany. susana.minguet@biologie.uni-freiburg.de.; Center of Chronic Immunodeficiency CCI, University Clinics and Medical Faculty, Freiburg, Germany. susana.minguet@biologie.uni-freiburg.de.

Publikováno v: Nature immunology [Nat Immunol] 2021 Jan; Vol. 22 (1), pp. 100-101.

Advances in CAR-T-cell therapy in T-cell malignancies.

Autor: Zheng, Rubing¹ (AUTHOR), Zhu, Xiaojian¹ (AUTHOR) zhuxiaojian@hust.edu.cn, Xiao, Yi¹ (AUTHOR) yixiao@tjh.tjmu.edu.cn

Publikováno v: Journal of Hematology & Oncology. 6/24/2024, Vol. 17 Issue 1, p1-19. 19p.

Tyrosine 192 within the SH2 domain of the Src-protein tyrosine kinase p56^Lck regulates T-cell activation independently of Lck/CD45 interactions.

Autor: Kästle, Matthias^1,2 (AUTHOR), Merten, Camilla^1,2 (AUTHOR), Hartig, Roland^1,2 (AUTHOR), Kaehne, Thilo³ (AUTHOR), Liaunardy-Jopeace, Ardiyanto⁴ (AUTHOR), Woessner, Nadine M.^5,6,7 (AUTHOR), Schamel, Wolfgang W.^6,7 (AUTHOR), James, John^4,8 (AUTHOR), Minguet, Susana^6,7 (AUTHOR), Simeoni, Luca^1,2 (AUTHOR) Luca.simeoni@med.ovgu.de, Schraven, Burkhart^1,2 (AUTHOR) Burkhart.schraven@med.ovgu.de

Publikováno v: Cell Communication & Signaling. 11/23/2020, Vol. 18 Issue 1, pN.PAG-N.PAG. 1p.